作者: Kenneth C. Chu , Charisee A. Lamar , Harold P. Freeman
DOI: 10.1002/CNCR.11411
关键词:
摘要: BACKGROUND Black females have lower breast carcinoma survival rates compared with white females. One possible reason is that black more advanced-stage disease. Another factor may be racial differences in the utilization of cancer treatments. METHODS The authors determined 6-year stage specific rates, adjusting for age and treatments (using estrogen receptor [ER] status), to determine whether there were treatment. Racial distributions disease used examine impact factors on diagnosis. RESULTS For all cases, general, significantly stages combined Stages I–III every group. However, examination by different treatments, as measured ER status, revealed some results. Only women younger than 50 years ER-positive tumors 65 ER-negative had stage-specific rates. In addition, distribution analyses showed group less Stage I disease. CONCLUSIONS For (younger years), was evidence treatment both tumors, indicated their contrast, or older lack a significant difference rate suggests Medicare help alleviate disparities Furthermore, need earlier diagnosis age. 2003;97:2853–60. Published 2003 American Cancer Society. DOI 10.1002/cncr.11411